The report "Biobanking Market by product type (Equipment (Incubators, Centrifuges, Alarm and Monitoring Systems, Temperature Control Systems, Others), Consumables), by sample type (Biological Fluids, Human Waste Products, Blood Products, Human Tissues, Cell Lines, Nucleic Acids), by application (Therapeutic Applications, Research Applications, Clinical Trials), by end-user (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, Research Institutes, Others) - Global Forecasts to 2030" The global biobanking market is projected to reach USD 43.8 billion in 2023, registering a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period 2024-2030. The growth of the market is majorly driven by the growing focus on mainstream precision medicine and the rise of genomic medicine/clinical genomics. The process of gathering and preserving biological materials for use in research, biodiversity studies, and diagnostics is known as biobanking. Biobanks are essential to the advancement of personalized treatment, the upkeep and updating of age demographic datasets, and scientific research projects. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=22456 Competitive Dashboard: The prominent key players operating in the global Biobanking market are Agilent Technologies Inc., Amgen Inc., Astrazeneca, Avantor Inc., Azenta Life Sciences, Biokryo Gmbh, Bruker Corp., Centogene N.V., Hamilton Co., Indivumed Gmbh, Merck Kgaa, Qiagen, Tecan Group Ltd., Thermo Fisher Scientific Inc. Regional Overview: The report also examines the current concerns and their Future Effects on the biobanking market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the biobanking market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
- The biobanking market research report includes historical data, trending features, and market growth estimates for the future.
- The qualitative and quantitative analysis of the market along with CAGR calculation for the forecast period.
- The biobanking market report helps to provide the best results for business enhancement and business growth.
- The report gives a comprehensive overview of both primary and secondary data.
- The biobanking market key players covered here to help them strengthen their place in the market.